Search

Your search keyword '"Tiroch K"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Tiroch K" Remove constraint Author: "Tiroch K" Search Limiters Full Text Remove constraint Search Limiters: Full Text
34 results on '"Tiroch K"'

Search Results

1. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

2. Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey

3. Ezetimibe added to statin therapy after acute coronary syndromes

4. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry

5. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

6. The Regime for Marine Scientific Research in the Arctic: Implications of the Absence of Outer Limits of the Continental Shelf beyond 200 Nautical Miles

7. Black Sea

10. Der humane Natrium-Iodid-Symporter in der Verwendung als kardiales Reportergen

11. The Regime for Marine Scientific Research in the Arctic: Implications of the Absence of Outer Limits of the Continental Shelf beyond 200 Nautical Miles

12. Der humane Natrium-Iodid-Symporter in der Verwendung als kardiales Reportergen

15. High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction?: A cross-sectional study

16. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

17. Der humane Natrium-Iodid-Symporter in der Verwendung als kardiales Reportergen

19. Minor defects of the luminal integrity in arterial introducer eSheaths after transcatheter aortic valve implantation.

20. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

21. Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve Replacement.

22. Single Center Retrospective Analysis of Conventional and Radial TIG Catheters for Transradial Diagnostic Coronary Angiography.

23. Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes?

25. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

26. Entanglement due to Delayed Removal of a Buddy Wire.

27. Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.

28. High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study.

29. Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention.

30. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.

31. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.

32. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.

33. No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.

34. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.

Catalog

Books, media, physical & digital resources